Chugai Pharmaceutical is a leading Japanese drugmaker majority-owned by Roche, strong in oncology and antibody drugs. It trades on the Tokyo Stock Exchange under code 4519, in the Pharmaceuticals sector.
Key Facts
| Item | Details |
|---|---|
| Ticker | 4519 |
| Exchange | Tokyo Stock Exchange (TYO: 4519) |
| Sector | Pharmaceuticals |
| Headquarters | Tokyo, Japan |
Bull Case & Risks
Bull Case
- The Roche partnership and royalty streams
- A strong antibody/oncology pipeline
- High RandD productivity
Risks
- Reliance on key drug royalties
- Patent and pricing risk
Outlook
Chugai pairs domestic strength with the Roche alliance, generating high-value antibody and oncology franchises.
Educational information only, not investment advice. Stocks carry risk including possible loss of principal; past performance does not guarantee future results.